{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-109665","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2024-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.413767+00:00","generated_at":"2026-05-31T01:31:21.283922+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Sight Sciences: Noridian final LCD confirms Medicare coverage for OMNI/SION but restricts certain uses","bullets":["Final LCD confirms Medicare coverage for phaco/IOL with single MIGS procedure (OMNI/SION) in 16 states.","Effective date of final LCD is November 17, 2024.","Non-coverage for first-line mild-to-moderate glaucoma, same-eye aqueous shunt, or multiple MIGS with cataract.","Company plans to continue engagement with MACs, CMS, and clinical societies."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-109665","json":"https://secwatch.observer/filing/0000950170-24-109665.json","markdown":"https://secwatch.observer/filing/0000950170-24-109665.md","text":"https://secwatch.observer/filing/0000950170-24-109665.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024109665/0000950170-24-109665-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024109665/sght-20240926.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:31:21.283922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}